Global Healthcare Fund Offers $70 Mn to Pinnacle Blooms Network for AI-Powered Child Development Platform

The first phase includes $70 million earmarked for expansion within India and technology development. A second phase envisions a follow-on tranche aligned with planned expansion into Southeast Asia and the GCC.

A leading global healthcare investment fund has offered $70 million to Pinnacle Blooms Network to support the scaling of its AI-powered child development operating system.

The proposed Series A investment, structured in two tranches and advised by Yukon Capital, is aimed at funding domestic expansion and technology acceleration.

Pinnacle Blooms Network is the pediatric therapy enterprise of Bharath Healthcare Laboratories Pvt. Ltd. The offer comes amid interest from multiple global institutional investors focused on the developmental health sector.

Pinnacle currently operates more than 70 multi-disciplinary therapy centres across India and has delivered over 20 million one-to-one therapy sessions. Its proprietary Pinnacle Child Development Operating System, known as GPT-OS, is a digital therapeutic platform designed to measure, forecast and personalise developmental therapy across speech, motor, cognitive and behavioural domains.

The GPT-OS platform integrates modules including Diagnosis, Prognosis, TherapeuticAI, AbilityScore, Seven Readiness Indexes and TherapySphere, which are multi-sensory therapeutic environments developed for children with autism, speech delays, ADHD and related conditions.

Under the proposed funding structure, the first phase includes $70 million earmarked for expansion within India and technology development. A second phase envisions a follow-on tranche aligned with planned expansion into Southeast Asia and the GCC.

According to the company, the capital would support growth from more than 70 centres to 300 centres within 24 months, research and development for home-based TherapeuticAI applications, manufacturing of TherapySphere sensory rooms and regulatory submissions for international markets.

Commenting on the proposed investment, Aneesh Madhav, chief executive officer of Yukon Capital, said, “We've advised on healthcare transactions across four continents, and Pinnacle is unlike anything we've seen. They've solved the fundamental problem in developmental health—how do you make therapy measurable, scalable, and accessible without losing the human element? GPT-OS® isn't a feature; it's infrastructure. This is the operating system layer for childhood development globally. The question isn't whether this category will attract institutional capital—it's who will move decisively enough to lead it.”

Dr. Koti Reddy Saripalli, founder and chairman of Bharath Healthcare Laboratories, said the company’s focus has remained on building measurable therapy outcomes.

“Fourteen years ago, we began with one conviction: no parent should ever be told there's nothing more that can be done for their child. Today, we've delivered 20 million therapy sessions, and every single one generated data that makes the next session smarter,” he said.

Dr. Sreeja Reddy Saripalli, co-founder and clinical director, highlighted the role of data visibility for families. “For too long, parents have been given hope without evidence. They were told 'trust the process' but never shown the progress. We changed that,” she said.

According to the company, Pinnacle’s therapy data is structured in line with WHO ICD-11, ICF and ICHI standards. It holds ISO 13485:2016 certification for quality management systems for medical devices and ISO/IEC 27001:2022 certification for information security management.

Pinnacle said it is also running multiple clinical research programmes, including the AbilityScore® Longitudinal Study, the TherapeuticAI® Effectiveness Study and the TherapySphere™ Sensory Environment Study, aimed at generating real-world evidence for regulatory submissions and peer-reviewed publication.

The company is targeting expansion from over 70 therapy centres to more than 300 centres within 24 months and 600 centres within four years. It is also planning geographic expansion beyond India into Southeast Asia and the GCC, alongside scaling its home-based therapy platform.

Stay tuned for more such updates on Digital Health News